Herpes Simplex Virus 1 Tegument Protein UL41 Counteracts IFIT3 Antiviral Innate Immunity.
The interferon-induced protein with tetratricopeptide repeat 3 (IFIT3 or ISG60) is a host-intrinsic antiviral factor that restricts many instances of DNA and RNA virus replication. Herpes simplex virus 1 (HSV-1), a DNA virus bearing a large genome, can encode many viral proteins to counteract the host immune responses. However, whether IFIT3 plays a role upon HSV-1 infection is little known. In this study, we show for the first time that HSV-1 tegument protein UL41, a viral endoribonuclease, plays an important role in inhibiting the antiviral activity of IFIT3. Here, we demonstrated that ectopically expressed IFIT3 could restrict the replication of vesicular stomatitis virus (VSV) but had little effect on the replication of wild-type (WT) HSV-1. Further study showed that WT HSV-1 infection downregulated the expression of IFIT3, and ectopic expression of UL41, but not the immediate-early protein ICP0, notably reduced the expression of IFIT3. The underlying molecular mechanism was that UL41 diminished the accumulation of IFIT3 mRNA to abrogate its antiviral activity. In addition, our results illustrated that ectopic expression of IFIT3 inhibited the replication of UL41-null mutant virus (R2621), and stable knockdown of IFIT3 facilitated its replication. Taking these findings together, HSV-1 was shown for the first time to evade the antiviral function of IFIT3 via UL41.


OBJECTIVE
The tegument protein UL41 of HSV-1 is an endoribonuclease with the substrate specificity of RNase A, which plays an important role in viral infection. Upon HSV-1 infection, interferons are critical cytokines that regulate immune responses against viral infection. Host antiviral responses are significantly boosted or crippled in the presence or absence of IFIT3; however, whether IFIT3 plays a role during HSV-1 infection is still unknown. Our data show for the first time that IFIT3 has little effect on HSV-1 replication, as UL41 decreases the accumulation of IFIT3 mRNA and subverts its antiviral activity. This study identifies IFIT3 as a novel target of the tegument protein UL41 and provides new insight into HSV-1-mediated immune evasion.
Institutes of Biology and Medical Sciences, Soochow University, Suzhou, China.
Zhangtao
Z
Jiang
Institutes of Biology and Medical Sciences, Soochow University, Suzhou, China.
Chenhe
C
Su
Institutes of Biology and Medical Sciences, Soochow University, Suzhou, China zheng.alan@hotmail.com.|Department of Microbiology, Immunology and Infectious Diseases, University of Calgary, Calgary, Alberta, Canada.
Chunfu
C
Zheng
D000818:Animals; D002522:Chlorocebus aethiops; D005786:Gene Expression Regulation; D057809:HEK293 Cells; D018259:Herpesvirus 1, Human / Q000235:genetics / Q000276:immunology*; D006801:Humans; D017874:Immediate-Early Proteins / Q000235:genetics / Q000276:immunology*; D057131:Immune Evasion; D007113:Immunity, Innate; D047908:Intracellular Signaling Peptides and Proteins / Q000037:antagonists & inhibitors / Q000235:genetics / Q000276:immunology*; D012333:RNA, Messenger / Q000235:genetics / Q000276:immunology*; D034741:RNA, Small Interfering / Q000235:genetics / Q000378:metabolism; D015398:Signal Transduction; D013045:Species Specificity; D044767:Ubiquitin-Protein Ligases / Q000235:genetics / Q000276:immunology*; D014709:Vero Cells; D018116:Vesiculovirus / Q000235:genetics / Q000276:immunology; D014764:Viral Proteins / Q000235:genetics / Q000276:immunology*; D014779:Virus Replication
C116468:IFIT3 protein, human; D017874:Immediate-Early Proteins; D047908:Intracellular Signaling Peptides and Proteins; D012333:RNA, Messenger; D034741:RNA, Small Interfering; C081688:Ul41 protein, Human herpesvirus 1; D014764:Viral Proteins; D044767:Ubiquitin-Protein Ligases; C051804:Vmw110 protein, Human herpesvirus 1
J Virol. 2012 Apr;86(7):3528-40
22301138
J Virol. 2011 Feb;85(4):1881-6
21147926
Cell Microbiol. 2006 Jun;8(6):907-22
16681834
Proc Natl Acad Sci U S A. 2004 Mar 9;101(10):3603-8
14993598
Wiley Interdiscip Rev RNA. 2013 Nov-Dec;4(6):693-708
23900973
Acta Biochim Biophys Sin (Shanghai). 2013 Oct;45(10 ):867-74
23942572
J Virol. 2012 Jan;86(1):473-83
22013045
J Virol. 2014 Oct;88(20):12163-6
25078699
Nature. 2013 Feb 7;494(7435):60-4
23334420
Int J Biol Sci. 2013;9(2):200-8
23459883
J Virol. 2015 Mar;89(5):2462-8
25428874
J Virol. 2013 Dec;87(23 ):12935-48
24067962
J Interferon Cytokine Res. 2013 Apr;33(4):199-205
23570386
J Virol. 2010 Oct;84(20):10671-80
20686046
J Virol. 2004 Feb;78(3):1063-8
14722261
J Virol. 2016 May 27;90(12 ):5824-9
27076640
Folia Microbiol (Praha). 2000;45(1):7-28
11200675
J Virol. 2008 Jun;82(11):5527-35
18367525
Biofactors. 2009 Jan-Feb;35(1):14-20
19319841
Trends Immunol. 2012 Apr;33(4):190-7
22321608
Virol J. 2015 Dec 01;12:203
26625984
Science. 1990 Nov 30;250(4985):1262-6
2173860
Nat Rev Microbiol. 2011 May;9(5):382-94
21494278
Antiviral Res. 2013 Sep;99(3):197-206
23791982
Nat Rev Immunol. 2013 Jan;13(1):46-57
23237964
J Virol. 2013 Jan;87(1):94-109
23077305
Virus Res. 2009 Aug;143(2):222-34
19651457
Nucleic Acids Res. 2014 Mar;42(5):3228-45
24371270
J Immunol. 2011 Sep 1;187(5):2559-68
21813773
PLoS One. 2013 Nov 04;8(11):e79518
24223959
Arch Virol. 2011 Dec;156(12):2267-72
21894520
PLoS Pathog. 2012;8(5):e1002712
22615570
Cell Signal. 2008 Jan;20(1):112-9
17933493
Acta Virol. 2011;55(1):69-73
21434707
J Virol. 2011 Nov;85(21):11079-89
21835786
J Virol. 2010 Dec;84(24):13036-9
20926571
Nature. 2011 Apr 28;472(7344):481-5
21478870
J Virol. 2010 Jul;84(13):6886-90
20427534
J Virol. 1985 Sep;55(3):601-10
4020960
J Virol. 2011 Dec;85(23):12662-72
21937652
J Virol. 2013 Dec;87(24):13115-23
24067977
Front Immunol. 2014 Mar 10;5:94
24653722
Nat Rev Immunol. 2008 Jul;8(7):559-68
18575461
J Virol. 2002 Sep;76(17):8560-71
12163576
Mediators Inflamm. 2015;2015:593757
25918478
Proc Natl Acad Sci U S A. 2004 Dec 28;101(52):18165-70
15596716
Cell Signal. 2015 Dec;27(12):2343-54
26334375
J Virol. 2006 Sep;80(18):9341-5
16940547
J Virol. 1983 May;46(2):498-512
6302315
Nature. 2010 Nov 18;468(7322):452-6
21085181
J Virol. 2013 May;87(9):5005-18
23427152
J Biol Chem. 2006 Nov 10;281(45):34064-71
16973618
J Virol. 1995 Nov;69(11):6779-86
7474089
J Virol. 2001 Nov;75(21):10272-80
11581395